Prof. Dr. Aydın TÜRKMEN

Yayın Ağı

Makaleler 207

1. Biopsy-proven BK virus nephropathy in renal transplant recipients: A multi-central study from Turkey (BK-TURK STUDY)

Gungor O., Dheir H., Islam M., Toz H., YILDIZ A., Sinangil A., et al.

Clinical Nephrology , cilt.102, sa.4, ss.202-211, 2024 (SCI-Expanded)

2. Prognostic factors and validation of the histologic chronicity score for C3 glomerulopathy: a registry analysis

Mirioglu Ş., Cebeci E., Yazici H., DERİCİ Ü., Sahin G., ÇOBAN G., et al.

CLINICAL KIDNEY JOURNAL , cilt.17, sa.8, 2024 (SCI-Expanded)

3. Post-COVID-19 Outcomes of Patients with Primary Glomerular Diseases: A Nationwide Controlled Study

Öztürk S., Karadağ S., ARICI M., Türkmen A., Turgutalp K., Aktaş N., et al.

Turkish Journal of Nephrology , cilt.33, sa.2, ss.179, 2024 (ESCI) Sürdürülebilir Kalkınma

4. Outcome and Risk Factors for Mortality in Peritoneal Dialysis Patients: 22 Years of Experience in a Turkish Center

Demir E., Çalişkan Y., Goksoy Y., Sacli F. S., Mutlu U., Türkmen A., et al.

Turkish Journal of Nephrology , cilt.33, sa.2, ss.223, 2024 (ESCI)

5. Thromboembolic complications after COVID-19 in kidney transplant recipients.

Artan A. S., Dirim A. B., Yavuzkilic H., Demir E., Oto Ö. A., Guller N., et al.

Nephrology (Carlton, Vic.) , cilt.29, sa.1, ss.39-47, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

6. Do Xenogeneic Anti-HLA-A3 Antibody Cause AntibodyMediated Rejection in Kidney Transplant?

Akgul S., Temurhan S., Çınar Ç., Şentürk Çiftçi H., Bayraktar A., Demir E., et al.

TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.33, sa.1, ss.102-109, 2024 (Hakemli Dergi)

7. Diagnostic yield and safety of percutaneous native kidney biopsy in pregnancy: 20-years of single-center experience.

Yazici H., Dirim A. B., Garayeva N., Safak S., Ozluk Y., Hurdogan O., et al.

Journal of nephrology , cilt.36, sa.9, ss.2507-2517, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

8. An atypical case of refractory passenger lymphocyte syndrome after renal transplantation.

Dirim A. B., Demir E., Safak S., Garayeva N., Artan A. S., Oto O. A., et al.

Nefrologia , cilt.43, sa.6, ss.783-788, 2023 (Hakemli Dergi)

9. Pregnancy in Living Kidney Donors: An Evidence-Based Review

ARTAN A. S., Fleetwood V., Guller N., OTO Ö. A., Mirioglu Ş., Caliskan Y., et al.

CURRENT TRANSPLANTATION REPORTS , cilt.10, sa.3, ss.110-116, 2023 (ESCI) Sürdürülebilir Kalkınma

10. Concurrent CobalaminC and plasminogen deficiencies in a patient with chronic thrombotic microangiopathy

DİRİM A. B., Safak S., BALCI M. C., Ozyavuz P., Garayeva N., TİRYAKİ T. O., et al.

NEPHRON , 2023 (SCI-Expanded, Scopus)

11. Nephrotic syndrome and acute tubular injury after bee stings in a beekeeper: expanding the electron microscopic findings of bee venom-induced renal injury

Safak S., Dirim A. B., Solakoglu S., Garayeva N., Demir E., Artan A. S., et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.55, sa.8, ss.2131-2132, 2023 (SCI-Expanded)

12. Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?

MİRİOĞLU Ş., Akyildiz A., uçar a. r., ULUDAĞ Ö., ÖZLÜK Y., DİRİM A. B., et al.

TURKISH JOURNAL OF NEPHROLOGY , cilt.32, sa.3, ss.209-215, 2023 (ESCI) Sürdürülebilir Kalkınma

13. Kidney Transplantation in Patients Recovered from Coronavirus Disease 2019

ARTAN A. S., SADİOĞLU R. E., Yelken B., Yalcin F., DEMİR E., KEVEN K., et al.

Turkish journal of nephrology (Online) , cilt.32, sa.3, ss.228-234, 2023 (Hakemli Dergi)

14. A comparison of methods of plasmapheresis for the treatment of late antibody mediated rejection in kidney transplant recipients

Caliskan Y., Mirioglu Ş., Dirim A. B., Ozluk Y., Yegit O. O., Aksoy E., et al.

THERAPEUTIC APHERESIS AND DIALYSIS , cilt.27, sa.3, ss.428-434, 2023 (SCI-Expanded, Scopus)

15. Efficacy and safety of interleukin-1 blockers in kidney transplant recipients with familial Mediterranean fever: a propensity score-matched cohort study

Mirioglu Ş., Dirim A. B., Bektas M., Demir E., Tor Y. B., Ozluk Y., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.38, sa.5, ss.1327-1336, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

16. Propensity score-matched analysis of long-term outcomes for living kidney donation in alternative complement pathway diseases: a pilot study

Caliskan Y., Safak S., Oto Ö. A., Velioglu A., Yelken B., Mirioglu Ş., et al.

JOURNAL OF NEPHROLOGY , cilt.36, sa.4, ss.979-986, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

17. Spatial Distribution of Macrophage Subtypes Among Rejection Subtypes in Renal Transplant Biopsies by Dual Immunohistochemistry

Hurdogan O., Karakus F., Dirim A. B., Aksu B., Saygili S., Turkmen A., et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , cilt.31, sa.4, ss.224-231, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

18. Outcomes of kidney transplantation in patients with congenital anomalies of the kidney and urinary tract: a propensity-score-matched analysis with case-control design

OTO Ö. A., Mirioğlu Ş., Yazici H., DİRİM A. B., Güller N., Şafak S., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.53, sa.2, ss.526-535, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

19. Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational Study

Artan A. S., Mirioğlu Ş., İstemihan Z., Aksoy E., Dirim A. B., Çavuş B., et al.

BALKAN MEDICAL JOURNAL , cilt.40, sa.3, ss.182-187, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

20. Expression of JC virus in a kidney transplant recipient with renal cell carcinoma.

Garayeva N., Demir E., Dirim A. B., Şafak Öztürk S., Artan A. S., Özlük M. Y., et al.

Nefrologia , cilt.6, sa.22, ss.153-155, 2022 (Hakemli Dergi)

21. Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy

Vart P., Duivenvoorden R., Adema A., Covic A., Finne P., Braak N. H., et al.

Scientific Reports , cilt.12, sa.1, 2022 (SCI-Expanded)

22. Long-Term Outcomes of Living-Related Kidney Donation for Alport Syndrome Spectrum: A Propensity Score-Matched Analysis

Oto Ö. A., Safak S., Mirioglu Ş., Yelken B., Velioglu A., Dirim A. B., et al.

AMERICAN JOURNAL OF NEPHROLOGY , sa.8-9, ss.628-635, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

23. Efficacy of intravenous combined immunosuppression with plasmapheresis in adult patients with refractory primary focal segmental glomerulosclerosis.

Dirim A. B., Demir E., Guller N., Safak S., Artan A. S., Oto Ö. A., et al.

Journal of clinical apheresis , cilt.37, sa.4, ss.376-387, 2022 (SCI-Expanded)

24. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

Hemmelder M. H., Noordzij M., Vart P., Hilbrands L. B., Jager K. J., Abrahams A. C., et al.

Nephrology Dialysis Transplantation , cilt.37, sa.6, ss.1140-1151, 2022 (SCI-Expanded)

25. Oxidative stress and macrophage infiltration in IgA nephropathy

Caliskan Y., Demir E., Karatay E., Ozluk Y., Mirioglu Ş., Dirim A. B., et al.

JOURNAL OF NEPHROLOGY , sa.4, ss.1101-1111, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. MALIGNANCY AFTER KIDNEY TRANSPLANTATION: A TWO-CENTER

Demir E., Dincer M. T., KARACA C., Erel C., Karahan L., PEKMEZCİ A., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.37, 2022 (SCI-Expanded)

27. COVID-19 in Kidney Transplant Recipients: A Multicenter Experience from the First Two Waves of Pandemic

DEMİR E., Ucar Z. A., Dheir H., Danis R., Yelken B., Uyar M., et al.

BMC NEPHROLOGY , cilt.23, sa.1, 2022 (SCI-Expanded)

28. Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients

Demir E., DHEİR H., Safak S., Artan A. S., SİPAHİ S., Turkmen A.

VACCINE , cilt.40, sa.24, ss.3313-3319, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

29. Genotype-Phenotype correlations of SCARB2 associated clinical presentation: a case report and in-depth literature review

Atasu B., Acarli A. N. O., Bilgic B., Baykan B., Demir E., Ozluk Y., et al.

BMC NEUROLOGY , cilt.22, sa.1, 2022 (SCI-Expanded, Scopus)

30. Impact of the COVID-19 pandemic on interest in renal diseases.

Oto Ö. A., Kardeş S., Guller N., Safak S., Dirim A. B., Başhan Y., et al.

Environmental science and pollution research international , cilt.29, sa.1, ss.711-718, 2022 (SCI-Expanded)

31. Antibody response to two doses of inactivated SARS-CoV-2 vaccine (CoronaVac) in kidney transplant recipients

Sadioglu R. E., Demir E., EVREN E., Aktar M., Safak S., Artan A. S., et al.

TRANSPLANT INFECTIOUS DISEASE , cilt.23, sa.6, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

32. Expression of JC virus in a kidney transplant recipient with renal cell carcinoma

Garayeva N., Demir E., Dirim A. B., Safak S., Artan A. S., Ozluk Y., et al.

Nefrologia , cilt.1, ss.1, 2021 (SCI-Expanded)

33. LIMS1 risk genotype and T cell-mediated rejection in kidney transplant recipients

Caliskan Y., Karahan G., Akgul S. U., Mirioglu Ş., Ozluk Y., Yazici H., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , sa.11, ss.2120-2129, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

34. COVID-19 in chronic kidney disease: a retrospective, propensity score-matched cohort study

Dirim A. B., Demir E., Yadigar S., Garayeva N., Parmaksiz E., Safak S., et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.53, sa.10, ss.2117-2125, 2021 (SCI-Expanded, Scopus)

35. The relationship between glomerular IgG staining and poor prognostic findings in patients with IgA nephropathy: the data from TSN-GOLD working group

TURGUTALP K., Cebeci E., Turkmen A., DERİCİ Ü., SEYAHİ N., EREN N., et al.

BMC NEPHROLOGY , cilt.22, sa.1, 2021 (SCI-Expanded)

36. Page Kidney: A Rare Cause of Resistant Hypertension Early After Renal Transplantation.

Dirim A. B., Demir E., Oto Ö. A., Yazıcı H., Türkmen A.

Balkan medical journal , cilt.38, sa.5, ss.316-317, 2021 (SCI-Expanded)

37. Significance of caveolin-1 immunohistochemical staining differences in biopsy samples from kidney recipients with BK virus viremia

Arpali E., Sunnetcioglu E., Demir E., Saglam A., Ozluk Y., VELİOĞLU A., et al.

TRANSPLANT INFECTIOUS DISEASE , cilt.23, sa.4, 2021 (SCI-Expanded)

38. Reinfection with SARS-CoV-2 in a kidney transplant recipient

Amikishiyev S., Demir E., Aghamuradov S., Garayeva N., Artan A. S., Gül A., et al.

TRANSPLANT INFECTIOUS DISEASE , cilt.23, sa.4, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

39. Risk factors, pathogenesis, presentation and management of BK virus infection in kidney transplantation

Demir E., Turkmen A., Sever M. S.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.36, sa.6, ss.985-987, 2021 (SCI-Expanded)

40. Characteristics of primary glomerular diseases patients with hematuria in Turkey: the data from TSN-GOLD Working Group.

Sumnu A., TÜRKMEN K., Cebeci E., Turkmen A., EREN N., Seyahi N., et al.

International urology and nephrology , cilt.53, sa.5, ss.945-954, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

41. Successful treatment of a COVID-19 patient with thrombotic microangiopathy

Safak S., Aksoy E., Dirim A. B., Demir E., Garayeva N., Oto O. A., et al.

CLINICAL KIDNEY JOURNAL , cilt.14, sa.4, ss.1287-1288, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

42. Epidemiological features of primary glomerular disease in Turkey: a multicenter study by the Turkish Society of Nephrology Glomerular Diseases Working Group.

Turkmen A., Sumnu A., Cebeci E., Yazici H., Eren N., Seyahi N., et al.

BMC nephrology , cilt.21, ss.481, 2020 (SCI-Expanded, Scopus)

43. Fatal SARS-CoV-2 infection in a renal transplant recipient.

Dirim A. B., Demir E., Ucar A., Garayeva N., Safak S., Oto Ö. A., et al.

CEN case reports , cilt.9, ss.409-412, 2020 (ESCI, Scopus) Sürdürülebilir Kalkınma

44. COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul.

Demir E., Uyar M., Parmaksiz E., Sinangil A., Yelken B., Dirim A. B., et al.

Transplant infectious disease : an official journal of the Transplantation Society , cilt.22, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

45. Presence of m-type phospholipase A2 receptor antibody in membranous nephropathy

OTO Ö. A., YAZICI H., Caliskan Y., ARTAN A. S., SEVER M. Ş., Cebeci E., et al.

Turkish Journal of Nephrology , cilt.29, sa.4, ss.258-263, 2020 (SCI-Expanded)

46. Hydroxychloroquine-Associated Hypoglycemia in Hemodialysis Patients With COVID-19

Dirim A. B., Demir E., Safak S., Garayeva N., Ucar A. R., Oto Ö. A., et al.

KIDNEY INTERNATIONAL REPORTS , cilt.5, sa.10, ss.1811-1814, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. Comparison of Oral Findings of Common Variable Immune Deficiency and Nephrotic Syndrome Patients with Hypogammaglobulinemia to Healthy Individuals

Çakır Karabaş H., Özcan İ., Güler Ö., Ar M. C., Çağatay A. A., Türkmen A.

International Journal of Oral and Dental Health , cilt.6, sa.3, ss.1-5, 2020 (Hakemli Dergi)

48. Case report: A kidney transplant patient with mild COVID-19

Arpali E., Akyollu B., Yelken B., Tekin S., TÜRKMEN A., Kocak B.

TRANSPLANT INFECTIOUS DISEASE , cilt.22, sa.4, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

49. THE RELATIONSHIP BETWEEN CCL2 AND CCL5 GEN EXPRESSIONS AND ALLOGRAFT FUNCTION IN PATIENTS UNDERGOING RENAL TRANSPLANTATION

Verep S., Hayriye S. C., Oktar T. M., Ziylan O., KOÇAK T., ERDEM S., et al.

HLA , cilt.95, sa.4, ss.310, 2020 (SCI-Expanded)

50. Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?

Bayraktar A., Akgul S. U., Bakkaloglu H., Temurhan S., Cinar Ç., Ciftci H. S., et al.

TRANSPLANTATION PROCEEDINGS , cilt.52, sa.1, ss.97-101, 2020 (SCI-Expanded)

51. New Bio-Markers: Cell-Free DNAs and MICRO-RNAs

Eksioglu-Demiralp E., Elbasi M. O., Turkmen A.

TURKISH JOURNAL OF NEPHROLOGY , cilt.28, sa.4, ss.310-320, 2019 (ESCI)

52. OUTCOME OF RENAL TRANSPLANTATION IN PATIENTS WITH DIABETES MELLITUS: A SINGLE - CENTER EXPERIENCE

Yelken B., Arpali E., AKAGÜN T., Akyollu B., Karatas C., Kocak B., et al.

TRANSPLANT INTERNATIONAL , cilt.32, ss.238, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

53. THE ASSESSMENT OF RENAL TRANSPLANT PATIENTS REGARDING MICRO-ELIMINATION OF CHRONIC VIRAL HEPATITISES IN TURKEY: AN ANALYSIS OF 2410 PATIENTS

Turkmen A., Bakir E. A., Bolukbas C., Sinangil A., Kocak E., Uyar M., et al.

TRANSPLANT INTERNATIONAL , cilt.32, ss.194, 2019 (SCI-Expanded)

54. Co-Deposition of IgM and C3 May Indicate Unfavorable Renal Outcomes in Adult Patients with Primary Focal Segmental Glomerulosclerosis

Mirioglu Ş., Caliskan Y. K., Ozluk Y., Dirim A. B., Istemihan Z., AKYILDIZ A., et al.

KIDNEY & BLOOD PRESSURE RESEARCH , sa.5, ss.961-972, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

55. Infectious Complications of Induction Therapies in Kidney Transplantation

Bayraktar A., Catma Y., Akyildiz A., Demir E., Bakkaloglu H., Ucar A. R., et al.

ANNALS OF TRANSPLANTATION , cilt.24, ss.412-417, 2019 (SCI-Expanded)

56. Panel Reactive Antibody Responses Against Influenza Vaccination in Kidney Transplant Recipients

Khıshıgsuren B., Demır E., Akgul S., Temurhan S., Ucar A., Dırım A. B., et al.

TRANSPLANTATION PROCEEDINGS , cilt.51, sa.4, ss.1115-1117, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

57. EFFECTS OF DIFFERENT VOLATILE ANESTHETICS ON ANTI-INFLAMMATORY CYTOKINE TGF-BETA1 REALEASE IN LIVING RENAL TRANSPLANT RECIPIENTS

Ciftci H., Karadeniz M. S., Tefik T., Turkmen A., Savran F., Tugrul K. M.

HLA , cilt.93, sa.5, ss.304-305, 2019 (SCI-Expanded)

58. Effects of Rituximab on Atherosclerotic Biomarkers in Kidney Transplant Recipients.

Alıyeva N., Demır E., Akgul S., Temurhan S., Ucar A., Dırım A. B., et al.

Transplantation proceedings , cilt.51, sa.4, ss.1118-1120, 2019 (SCI-Expanded)

59. Effects of Different Volatile Anesthetics on Cytokine and Chemokine Production After Ischemia-Reperfusion Injury in Patients Undergoing Living-Donor Kidney Transplant.

Karadeniz M., Ciftci H., Tefik T., Oktar T. M., Nane İ., Turkmen A., et al.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation , cilt.17, ss.68-74, 2019 (SCI-Expanded)

60. Fabry Disease Prevalence in Renal Replacement Therapy in Turkey

Yalin S. F., EREN N., Sinangil A., YILMAZ V. T., Tatar E., Ucarf A. R., et al.

NEPHRON , cilt.142, sa.1, ss.26-33, 2019 (SCI-Expanded)

61. Serum and Urinary Levels of Tumor Necrosis Factor-Alpha in Renal Transplant Patients.

Ciftci H., Demir E., Karadeniz M., Tefik T., Yazici H., Nane I., et al.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation , cilt.16, sa.6, ss.671-675, 2018 (SCI-Expanded)

62. Extreme hypercalcemia in a kidney transplant recipient

DEMIR E., KARAOGLAN C., Yegen G., SAIR B., YAZICI H., TURKMEN A., et al.

CEN CASE REPORTS , cilt.7, sa.2, ss.229-233, 2018 (ESCI)

63. Acute renal infarction in Turkey: a review of 121 cases

EREN N., Gungor O., KOÇYİĞİT İ., Guzel F. B., ERKEN E., ALTUNÖREN O., et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.50, sa.11, ss.2067-2072, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

64. Influence of uridine diphosphate-glucuronosyltransferases (1A9) polymorphisms on mycophenolic acid pharmacokinetics in patients with renal transplant.

CIFTCI H., Demir E., KARADENIZ M., TEFIK T., NANE I., OGUZ F., et al.

Renal failure , cilt.40, sa.1, ss.395-402, 2018 (SCI-Expanded)

65. Case report: C3 glomerulopathy advancing atypical hemolytic uremic syndrome

Catikkas M., Demir E., Ozluk Y., Caliskan Y., Badur R. M., Turkmen A.

NEFROLOGIA , cilt.38, sa.4, ss.450-452, 2018 (SCI-Expanded)

66. THE EFFECT OF HLA AND SNPS ON ESRD DEVELOPMENT IN IGAN PATIENTS

Kekik C., Temurhan S., Akgul S. U., Caliskan Y. K., Ozluk Y., Ertan S., et al.

HLA , cilt.91, sa.5, ss.438, 2018 (SCI-Expanded)

67. PHARMACOGENETIC EFFECTS OF URIDINE DIPHOSPHATE-GLUCURONOSYLTRANSFERASE POLYMORPHISMS ON MYCOPHENOLIC ACID PHARMACOKINETICS IN TURKISH RENAL TRANSPLANT PATIENTS

Ciftci H. S., Tefik T., Savran M. K., Demir E., Nane I., Savran F., et al.

HLA , cilt.91, sa.5, ss.381, 2018 (SCI-Expanded)

68. BIOMARKER FOR PROGRESSION OF IGA NEPHROPATHY

Temurhan S., Akgul S. U., Kekik C., Caliskan Y. K., Ozluk Y., Ertan S., et al.

HLA , cilt.91, sa.5, ss.371-372, 2018 (SCI-Expanded)

69. **Recurrent and de novo glomerulonephritis following renal transplantation: higher rates of rejection and lower graft survival**

Mirioglu Ş., Caliskan Y., Goksoy Y., Gulcicek S., Ozluk Y., Sarihan I., et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY , sa.12, ss.2265-2272, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

70. The effect of histopathologic and clinical features on allograft survival in renal transplant patients with antibody-mediated rejection.

AKAGUN T., YAZICI H., CALISKAN Y., Ozluk Y., SAHIN S., TURKMEN A., et al.

Renal failure , cilt.39, ss.19-25, 2017 (SCI-Expanded, Scopus)

71. Cardiovascular Parameters to 2 years After Kidney Transplantation Following Early Switch to Everolimus Without Calcineurin Inhibitor Therapy: An Analysis of the Randomized ELEVATE Study

Holdaas H., de Fijter J. W., Cruzado J. M., Massari P., Nashan B., Kanellis J., et al.

TRANSPLANTATION , cilt.101, sa.10, ss.2612-2620, 2017 (SCI-Expanded)

72. EFFECTS OF DIFFERENT VOLATILE ANAESTHETICS ON CXCL9 AND CXCL10 IN KIDNEY TRANSPLANT SURGERIES

Karadeniz M. S., Ciftci H., Tefik T., Erdem S., Nane I., Turkmen A., et al.

TRANSPLANT INTERNATIONAL , ss.529, 2017 (SCI-Expanded)

73. EFFECT OF RENAL CORTEX VOLUME ON POSTOPERATIVE GRAFT FUNCTION. DOES IT REALLY MATTERS?

Tefik T., Demir E., Yalcin M. C., Canitez I. O., Bulut A., Caliskan Y., et al.

TRANSPLANT INTERNATIONAL , cilt.30, ss.219, 2017 (SCI-Expanded)

74. LEVELS OF SERUM AND URINARY CXCL10 PREDICT FOR ACUTE REJECTION IN KIDNEY TRANSPLANTATION

Ciftci H., Demir E., Karadeniz M. S., Tefik T., HASBAL B., Caliskan Y., et al.

TRANSPLANT INTERNATIONAL , cilt.30, ss.111-112, 2017 (SCI-Expanded)

75. OUTCOMES OF PATIENTS WITH SUCCESSFUL DESENSITIZED RENAL TRANSPLANTATION: A SINGLE-CENTER STUDY

Turkmen A., Yelken B., Gorcin S., Yalcin F., Karatas C., Akyollu B., et al.

TRANSPLANT INTERNATIONAL , cilt.30, ss.385, 2017 (SCI-Expanded)

76. IMMEDIATE GRAFT NEPHRECTOMY AND RE-TRANSPLANTATION OF KIDNEY ALLOGRAFT FOLLOWING ACUTE RENAL VEIN THROMBOSIS

Tefik T., Bakkaloglu H., Oktar T. M., Bayraktar A., Demir E., Caliskan Y., et al.

TRANSPLANT INTERNATIONAL , cilt.30, ss.256-257, 2017 (SCI-Expanded)

77. THE RELEVANCE OF TUMOR NECROSIS FACTOR-ALPHA LEVELS IN KIDNEY TRANSPLANT RECIPIENTS

Ciftci H., Demir E., Karadeniz M. S., Tefik T., HASBAL B., Yazici H., et al.

HLA , cilt.89, sa.6, ss.395, 2017 (SCI-Expanded)

78. RELATIONSHIP BETWEEN HLA-DQA1, HLA-DQB1 AND HLA-DRB1 ALLELES IN IMMUNOGLOBULIN A NEPHROPATHY

Akgul S., Temurhan S., Kekik C., Caliskan Y. K., Artan S., Demir E., et al.

HLA , cilt.89, sa.6, ss.462, 2017 (SCI-Expanded)

79. Re-evaluation of glomerulitis using occlusion criteria based on the Banff 2013 revision: a retrospective study

Ozluk Y., Caliskan Y., Sevinc M., Bayram A., Arikan E., Turkmen A., et al.

TRANSPLANT INTERNATIONAL , cilt.30, sa.6, ss.579-588, 2017 (SCI-Expanded, Scopus)

80. GENETIC PREDICTORS OF RENAL SURVIVAL IN ALTERNATIVE COMPLEMENT PATHWAY ASSOCIATED GLOMERULOPATHIES

Torun E. S., Sarihan I., Mirioglu Ş., Akgul S., Temurhan S., Yildiz A., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.32, 2017 (SCI-Expanded)

81. C3 DEPOSITION MAY IMPLICATE DISEASE PROGRESSION IN PATIENTS WITH PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS

Mirioglu Ş., Dirim A. B., Istemihan Z., Akyildiz A., Ucar A., Ozluk Y., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.32, 2017 (SCI-Expanded)

82. EFFECTS OF IL-1 beta RECEPTOR ANTAGONIST IN KIDNEY TRANSPLANT RECIPIENTS

Demir E., Tacar S., Sarihan I., Torun E. S., Caliskan Y., Yazici H., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.32, 2017 (SCI-Expanded)

83. RITUXIMAB THERAPY FOR PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY RESISTANT TO CALCINEURIN INHIBITOR BASED THERAPY

Sacli S., Akyildiz A., Ucar A. R., Demir E., Yazici H., Turkmen A., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.32, ss.506, 2017 (SCI-Expanded)

84. PREDICTORS OF RENAL SURVIVAL IN PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY

Ucar A., Yegit O. O., Cebeci E., Yildiz A., Mirioglu Ş., Demir E., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.32, 2017 (SCI-Expanded)

85. Evaluation of T(H)17 and T(H)1 Immune Response Profile in Patients After Renal Transplant

EROL A., ARPALI E., Murat Y., KOCAK B., CALıSKAN Y., Nane I., et al.

TRANSPLANTATION PROCEEDINGS , cilt.49, sa.3, ss.467-471, 2017 (SCI-Expanded)

86. Prevalence of Human Herpesvirus-8 and BK Polyoma Virus Infections in End-stage Renal Disease and the Influence of Renal Transplantation

Turkmen A., Guven O., Mese S., Agacfidan A., YELKEN B., Onel M., et al.

TRANSPLANTATION PROCEEDINGS , cilt.49, sa.3, ss.436-439, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

87. Influence of Proton Pump Inhibitors on Mycophenolic Acid Pharmacokinetics in Patients With Renal Transplantation and the Relationship With Cytochrome 2C19 Gene Polymorphism.

Ciftci H., Karadeniz M., Tefik T., Caliskan Y. K., Yazıcı H., Demir E., et al.

Transplantation proceedings , cilt.49, sa.3, ss.490-496, 2017 (SCI-Expanded, Scopus)

88. Tac-MMF Versus CsA-MMF/CsA-AZA-Based Regimens in Development of De Novo Complement-Binding Anti-HLA Antibodies After Kidney Transplantation

Sahutoglu T., Akgul S., Caliskan Y. K., Yazici H., Demir E., Kara E., et al.

TRANSPLANTATION PROCEEDINGS , cilt.49, sa.3, ss.454-459, 2017 (SCI-Expanded)

89. Relevance of Flow Cytometric Auto-Crossmatch to the Post-transplant Course of Kidney Transplant Recipients

Demir E., Yeğit O. O., Erol A., Akgül S., Çalışkan B., Bayraktar A., et al.

TRANSPLANTATION PROCEEDINGS , cilt.49, sa.3, ss.477-480, 2017 (SCI-Expanded)

90. EFFECT OF URIDINE DIPHOSPHATE-GLUCURONOSYLTRANSFERASE POLYMORPHISMS ON THE PLASMA CONCENTRATIONS OF MYCOPHENOLIC ACID IN TURKISH RENAL TRANSPLANT PATIENTS

Senturk Ciftci H., Tefik T., Savran Karadeniz M., Demir E., Nane I., Savran Oguz F., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.80, sa.3, ss.104-110, 2017 (ESCI)

91. Pregnant Woman with Atypical Hemolytic Uremic Syndrome Delivered a Healthy Newborn under Eculizumab Treatment.

Demir E., Yazici H., Ozluk Y., Kilicaslan I., Turkmen A.

Case reports in nephrology and dialysis , cilt.6, ss.143-148, 2016 (ESCI, Scopus)

92. Serum Osteoprotegerin Levels Related With Cardiovascular Risk Factors in Chronic Kidney Disease

Demir P., Erdenen F., Aral H., Emre T., Kose S., Altunoglu E., et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS , cilt.30, sa.6, ss.811-817, 2016 (SCI-Expanded)

93. High soluble CD30 levels and associated anti-HLA antibodies in patients with failed renal allografts

Karahan G. E., Caliskan Y., Ozdilli K., Kekik C., Bakkaloglu H., Caliskan B., et al.

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS , cilt.39, sa.11, ss.547-558, 2016 (SCI-Expanded)

94. The role of midkine in the inflammatory process and its correlation with other inflammatory markers in renal transplant recipients.

Uzun S., Kaya B., Celik K., Behlul A., Ozkan O., Kuvvet M., et al.

The International journal of artificial organs , cilt.39, sa.6, ss.277-81, 2016 (SCI-Expanded)

95. The effect of C1q est done before kidney transplantation on acute rejections: Center experience

Yelken B., Yalcin F., Gorcin S., Karatas C., Akyollu B., Kocak B., et al.

TRANSPLANTATION , cilt.100, sa.7, 2016 (SCI-Expanded)

96. The frequency of pretransplant HHV-8 and BKV in renal transplant recipients and donors and the effect of renal transplantation on HHV-8 and BKV replications

Turkmen A., GUVEN O., Mese S., Agacfidan A., YELKEN B., GORCIN S., et al.

TRANSPLANTATION , cilt.100, sa.7, 2016 (SCI-Expanded)

97. The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg) positive donor and/or recipients: A center experience

Yelken B., Karatas C., Yonal O., Gorcin S., Akyollu B., Kocak B., et al.

TRANSPLANTATION , cilt.100, sa.7, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

98. THE PREDICTIVE VALUE OF CXCL9, CXCL10 LEVELS IN SERUM OF RENAL TRANSPLANT RECIPIENTS DURING REJECTION AT EARLY POST-TRANSPLANT PERIOD

Ciftci H. S., Ogret Y., Tefik T., Caliskan Y., Oktar T., Sanli O., et al.

HLA , cilt.87, sa.4, ss.255, 2016 (SCI-Expanded)

99. FREQUENCY OF DE NOVO ANTIBODY PRODUCTION FOR DQ, DRB3/4/5 AND COMMON CLASS I ANTIGENS (BW4/BW6) FOLLOWING KIDNEY TRANSPLANTATION: SINGLE ANTIGEN BEAD ARRAY PRA EXPERIENCE

Eksioglu-Demiralp E., TÜRKMEN A., Yelken B., Gorcin S., Yalcin F., Karatas C., et al.

HLA , cilt.87, sa.4, ss.250, 2016 (SCI-Expanded)

100. European Best Practice Guideline on Kidney Donor and Recipient Evaluation and Perioperative Care

KEVEN K., Turkmen A., SÜLEYMANLAR G.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.25, sa.1, ss.32-40, 2016 (ESCI) Sürdürülebilir Kalkınma

101. Management of Patients with a Failed Kidney Transplant

Yelken B., Akagun T., Turkmen A.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.25, ss.11-16, 2016 (ESCI)

102. ECULIZUMAB FOR DE NOVO HUS AFTER KIDNEY TRANSPLANTATION

Kocak B., Akyollu B., Karatas C., AkiNci S., Arpali E., Yelken B., et al.

TRANSPLANT INTERNATIONAL , cilt.28, ss.247, 2015 (SCI-Expanded)

103. THE EFFECT OF DONOR NEPHRECTOMY TECHNIQUE ON RECIPIENT LYMPHATIC DRAINAGE

Tefik T., Ciftci H. S., Kocak T., Sanli O., Ander H., Ziylan O., et al.

TRANSPLANT INTERNATIONAL , cilt.28, ss.607, 2015 (SCI-Expanded)

104. Eculizumab for Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: A Single-Center Experience

Yelken B., Arpali E., Gorcin S., Kocak B., Karatas C., Demiralp E., et al.

TRANSPLANTATION PROCEEDINGS , cilt.47, sa.6, ss.1754-1759, 2015 (SCI-Expanded)

105. Hyperuricemia is associated with progression of IgA nephropathy.

Bakan A., Oral A., Elcioglu O. C., Takir M., Kostek O., Ozkok A., et al.

International urology and nephrology , cilt.47, sa.4, ss.673-8, 2015 (SCI-Expanded)

106. An Important Problem: Posttransplant Focal Segmental Glomerulosclerosis Recurrence and Plasmapheresis

Emre T., KAZANCIOĞLU R., Dogan H., Caliskan Y. K., Kahvecioglu S., Turkmen A.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.24, sa.1, ss.47-54, 2015 (ESCI)

107. Demographic and clinical characteristics of primary glomerular diseases in Turkey

Ozturk S., Sumnu A., Seyahi N., Gullulu M., Sipahioglu M., Artan S., et al.

International Urology and Nephrology , cilt.46, sa.12, ss.2347-2355, 2014 (SCI-Expanded)

108. Pentraxin 3 and C-reactive protein as inflammatory markers after a kidney transplant.

Gursu M., Celik K., Ozturk S., Turkmen A., Gorcin S., Kocak B., et al.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation , cilt.12, sa.4, ss.295-9, 2014 (SCI-Expanded)

109. Elevated resistin levels are associated with inflammation in hemodialysis patients with failed renal allografts

Akagun T., Caliskan Y., Yazici H., Ozkok A., Telci A., Turkmen A., et al.

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS , cilt.37, sa.5, ss.358-363, 2014 (SCI-Expanded)

110. The Effects of Helicobacter pylori Eradication on Proteinuria in Patients with Primary Glomerulonephritis.

CALISKAN B., Yazici H., Caliskan Y. K., Ozluk Y., Gulluoglu M., Kilicaslan I., et al.

International journal of nephrology , cilt.2014, ss.180690, 2014 (SCI-Expanded)

111. INFLUENCE OF MDR1 GENE POLYMORPHISMS ON LIPID LEVELS IN RENAL TRANSPLANT PATIENTS

Ciftci H. S., Tefik T., Caliskan Y., Nane I., Turkmen A., Oguz F., et al.

TRANSPLANT INTERNATIONAL , cilt.26, ss.288, 2013 (SCI-Expanded)

112. MDR1 GENE POLYMORPHISM IN NORMO AND HYPERURICEMIC RENAL TRANSPLANT PATIENTS RECEIVING CYCLOSPORINE

Tefik T., Ciftci H. S., Kocak T., Ziylan O., Karadeniz M. S., Turkmen A., et al.

TRANSPLANT INTERNATIONAL , cilt.26, ss.290, 2013 (SCI-Expanded)

113. ECULIZUMAB IN KIDNEY TRANSPLANTATION: SHOULD WE CHANGE OUR TREATMENT ALGORITHM?

Turkmen A., Kocak B., Arpali E., Demiralp E., Gorcin S., Yelken B., et al.

TRANSPLANT INTERNATIONAL , cilt.26, ss.175, 2013 (SCI-Expanded)

114. Sexual Dysfunction in Women After Renal Transplantation

Kucuk L., Turkmen A., Küçük M.

SEXUALITY AND DISABILITY , cilt.31, sa.2, ss.155-166, 2013 (SSCI) Sürdürülebilir Kalkınma

115. Lipid parameters, doses and blood levels of calcineurin inhibitors in renal transplant patients.

Ciftci H., Ayna T. K., Calıskan Y. K., Turkmen A., Gurtekin M.

Indian journal of clinical biochemistry : IJCB , cilt.28, sa.2, ss.164-8, 2013 (Scopus) Sürdürülebilir Kalkınma

116. Eculizumab for Salvage Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: Case Reports

Kocak B., Arpali E., Demiralp E., Yelken B., Karatas C., Gorcin S., et al.

TRANSPLANTATION PROCEEDINGS , cilt.45, sa.3, ss.1022-1025, 2013 (SCI-Expanded)

117. Long-Term Effects of Antibodies against Human Leukocyte Antigens Detected by Flow Cytometry in the First Year after Renal Transplantation

Ayna T. K., Caliskan Y., Ciftci H., Turkmen A., Gurtekin M.

BALKAN MEDICAL JOURNAL , cilt.30, sa.1, ss.37-45, 2013 (SCI-Expanded)

118. The Effect of Antiproteinuric Treatment on Lipid Levels in Patients with Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy

Gursu M., Ozturk S., Kucuk H., Aydin Z., Sar F., YAZICI H., et al.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.22, sa.1, ss.72-77, 2013 (ESCI)

119. Drug Induced Gingival Overgrowth and Its Management

Kazancioglu H. O., Erisen M., Demirtas N., TÜRKMEN A., AK G.

JOURNAL OF ISTANBUL UNIVERSITY FACULTY OF DENTISTRY , cilt.47, sa.1, ss.66-72, 2013 (ESCI)

120. DİŞ ETİ BÜYÜMESİ MEYDANA GETİREN İLAÇLAR VE TEDAVİLERİ

AK G., KAZANCIOĞLU H. O., ERİŞEN M., DEMİRTAŞ N., TÜRKMEN A.

İstanbul Üniversitesi Diş Hekimliği Fakültesi Dergisi , cilt.47, sa.1, ss.66-72, 2013 (Hakemli Dergi)

121. Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever

Alpay N., Sumnu A., Caliskan Y., Yazici H., Turkmen A., Gül A.

RHEUMATOLOGY INTERNATIONAL , cilt.32, sa.10, ss.3277-3279, 2012 (SCI-Expanded)

122. Influence of Cytokine Gene Polymorphisms on Graft Rejection in Turkish Patients with Renal Transplants from Living Related Donors

Seyhun Y., Mytilineos J., Turkmen A., Oguz F., KEKİK Ç., Ozdilli K., et al.

TRANSPLANTATION PROCEEDINGS , cilt.44, sa.6, ss.1670-1678, 2012 (SCI-Expanded, Scopus)

123. Outcome of patients with amyloidosis after renal transplantation: a single-center experience

GURSU M., Yelken B., Caliskan Y., KAZANCIOĞLU R., Yazici H., Kilicaslan I., et al.

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS , cilt.35, sa.6, ss.444-449, 2012 (SCI-Expanded)

124. Anti- HLA antikorlarının saptanmasında akım sitometrik yöntemlerin önemi: Bir olgu nedeniyle

Kılıçaslan Ayna T., TÜRKMEN A., ŞENTÜRK ÇİFTÇİ H., GÜRTEKİN M.

Turkiye Klinikleri J Nephrol , cilt.7, sa.1, ss.27-30, 2012 (Hakemli Dergi)

125. Comparison of Markers of Appetite and Inflammation Between Hemodialysis Patients With and Without Failed Renal Transplants

Caliskan Y., Yelken B., Gorgulu N., Ozkok A., Yazici H., Telci A., et al.

JOURNAL OF RENAL NUTRITION , cilt.22, sa.2, ss.258-267, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

126. Colonic necrosis and perforation due to calcium polystyrene sulfonate in a uraemic patient: a case report.

AKAGUN T., Yazici H., GULLUOGLU M., YEGEN G., TURKMEN A.

NDT plus , cilt.4, ss.402-3, 2011 (SCI-Expanded)

127. Effects of arteriovenous fistula on clinical, laboratory and echocardiographic findings in renal allograft recipients

Gorgulu N., Caliskan Y., Yelken B., Akturk F., Turkmen A.

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS , cilt.34, sa.10, ss.1024-1030, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

128. INFLUENCE OF POLYMORPHISMS GLUTATHIONE S-TRANSFERASE AND ANTI-GSTT1 ANTIBODY ON ALLOGRAFT OUTCOME IN RENAL TRANSPLANT RECIPIENTS

Usta S., Caliskan Y., Gurkan H., Kekik Ç., Savran F., Turkmen A.

TRANSPLANT INTERNATIONAL , cilt.24, ss.303, 2011 (SCI-Expanded)

129. Appetite-regulating Hormones in Chronic Kidney Disease Patients

Oner-Iyidogan Y., Gurdol F., Kocak H., Oner P., Cetinalp-Demircan P., Caliskan Y., et al.

JOURNAL OF RENAL NUTRITION , cilt.21, sa.4, ss.316-321, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

130. Serum uric acid level is associated with cardiac hypertrophy in renal transplant recipients

Caliskan Y., Gorgulu N., Yelken B., Akturk F., Yazici H., Turkmen A., et al.

CLINICAL TRANSPLANTATION , cilt.25, sa.3, ss.368-374, 2011 (SCI-Expanded, Scopus)

131. Böbrek Nakli Sonrası Birinci Yılda Panel Reaktif Anti korların Akım Sitometri İle Takip Edilmesi

KILIÇASLAN AYNA T., ŞENTÜRK ÇİFTÇİ H., ÇALIŞKAN Y. K., Tozkır H., TÜRKMEN A., GÜRTEKİN M., et al.

Turkiye Klinikleri J Nephrol , cilt.6, sa.1, ss.1-11, 2011 (Hakemli Dergi)

132. Immunosuppressive Agents in the Treatment of Membranoproliferative Glomerulonephritis

Akagun T., Caliskan Y., Kaya O., YAZICI H., Yelken B., Alpay N., et al.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.20, sa.2, ss.173-177, 2011 (ESCI)

133. Treatment and Outcome of Idiopathic Focal Segmental Glomerulosclerosis: Immunosuppressive Agents or Renin Angiotensin System Inhibitors

Caliskan Y., Ozpolat H. T., YAZICI H., Yelken B., Gorgulu N., Aysuna N., et al.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.20, sa.3, ss.277-283, 2011 (ESCI)

134. Characterization of Minor HA-1 in Patients Who Underwent Living Donor Kidney Transplantation

Seyhun Y., Kekik Ç., Oguz F., Caliskan Y., Turkmen A., Carin M.

TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI , cilt.27, sa.3, ss.265-269, 2010 (SCI-Expanded)

135. Endothelial dysfunction in hemodialysis patients with failed renal transplants

Gorgulu N., Yelken B., Caliskan Y., Elitok A., Cimen A. O., Yazici H., et al.

CLINICAL TRANSPLANTATION , cilt.24, sa.5, ss.678-684, 2010 (SCI-Expanded, Scopus)

136. The need for blood products in patients with crush syndrome.

KAZANCIOGLU R., PINARBASI B., Esen B., Turkmen A., Sever M. Ş.

American journal of disaster medicine , cilt.5, ss.295-301, 2010 (Scopus)

137. Conversion to Sirolimus in Renal Transplant Recipients: A Single-Center Experience

Yelken B., Caliskan Y., Ozkan O., Gorgulu N., Yazici H., Turkmen A., et al.

ARTIFICIAL ORGANS , cilt.34, sa.8, 2010 (SCI-Expanded)

138. Akım Sitometrisi ile Böbrek Nakli Sonrası Vericiye Özgü Antikorların Monitorizasyonu

KILIÇASLAN AYNA T., ŞENTÜRK ÇİFTÇİ H., TÜRKMEN A., GÜRTEKİN M., ÇALIŞKAN Y. K., Çarin M.

TÜRK NEFROLOJİ DİYALİZ VE TRANSPLANTASYON DERGİSİ , cilt.19, sa.2, ss.94-101, 2010 (Hakemsiz Dergi)

139. Does pregnancy increase graft loss in female renal allograft recipients?

Gorgulu N., Yelken B., Caliskan Y., Turkmen A., Sever M. S.

CLINICAL AND EXPERIMENTAL NEPHROLOGY , cilt.14, sa.3, ss.244-247, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

140. The Current Status of Non-Biologic Liver Support in the Treatment of Liver Failure

Topaloglu S., Yankol Y., Kucukkartallar T., Ocak I., Dogruer K., Kocak B., et al.

JOURNAL OF MEDICAL AND SURGICAL INTENSIVE CARE MEDICINE , cilt.1, sa.1, ss.14-20, 2010 (ESCI) Sürdürülebilir Kalkınma

141. Outcomes of renal transplants from spousal donors: 25 years of experience at our center

Gorgulu N., Caliskan Y., Yelken B., Turkmen A.

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS , cilt.33, sa.1, ss.40-44, 2010 (SCI-Expanded)

142. Flow Cytometry Monitoring of Donor Specific Antibodies after Kidney Transplantation

Ayna T. K., ŞENTÜRK ÇİFTÇİ H., Caliskan Y., Gurtekin M., TÜRKMEN A., Carin M.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.19, sa.2, ss.94-101, 2010 (ESCI)

143. Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status

Karahan G. E., Kekik Ç., Oguz F., Onal A. E., Bakkaloglu H., Caliskan Y. K., et al.

RENAL FAILURE , cilt.32, sa.3, ss.380-383, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

144. The effect of the type of membrane on intradialytic complications and mortality in crush syndrome effect of dialyzer on outcomes in crush syndrome

Ozturk S., Kazancioglu R., Sahin G. M., Turkmen A., Gursu M., Sever M. S.

Renal Failure , cilt.31, sa.8, ss.655-661, 2009 (SCI-Expanded)

145. Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis

Oner-Iyidogan Y., Oner P., Kocak H., Gurdol F., Bekpinar S., Unlucerci Y., et al.

CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.3, ss.235-241, 2009 (SCI-Expanded)

146. Non-convulsive status epilepticus following antibiotic therapy as a cause of unexplained loss of consciousness in patients with renal failure

OZTURK S., KOCABAY G., Topcular B., Yazici H., Cagatay A. A., Bahat G., et al.

Clinical and Experimental Nephrology , cilt.13, sa.2, ss.138-144, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

147. PLASMA ACYLATED GHRELIN, OBESTATIN AND LEPTIN IN DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE PATIENTS

Oner-Iyidogan Y., Oner P., Gurdol F., Kocak H., Cetinalp-Demircan P., Caliskan Y., et al.

IUBMB LIFE , cilt.61, sa.3, ss.343, 2009 (SCI-Expanded)

148. EFFECT OF PRE-TRANSPLANT DIALYSIS MODALITY ON KIDNEY TRANSPLANTATION OUTCOME

Caliskan Y., Yazici H., Gorgulu N., Yelken B., Emre T., Turkmen A., et al.

PERITONEAL DIALYSIS INTERNATIONAL , cilt.29, 2009 (SCI-Expanded)

149. A Case of Focal Segmental Glomerulosclerosis Accompanied By Truncus Arteriosus: Effectiveness of Angiotensin Receptor Antagonist and Cyclosporine A

Caliskan Y., YAZICI H., Yelken B. M., Gorgulu N., KILIÇASLAN I., Demirturk M., et al.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.18, sa.3, ss.123-126, 2009 (ESCI)

150. Impact of HLA on the Underlying Primary Diseases in Turkish Patients with End-Stage Renal Disease

Karahan G. E., Seyhun Y., Oguz F. S., Kekik Ç., Onal A. E., Yazici H., et al.

RENAL FAILURE , cilt.31, sa.1, ss.44-49, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

151. BK Virus Nephropathy in Renal Transplant Recipients: A Single Centre Experience

Yelken B. M., KILIÇASLAN I., Caliskan Y., Gorgulu N., YAZICI H., TÜRKMEN A., et al.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.18, sa.3, ss.117-122, 2009 (ESCI)

152. Plasma ghrelin levels are associated with coronary microvascular and endothelial dysfunction in peritoneal dialysis patients.

Caliskan Y., Gorgulu N., Yelken B., Yazici H., Oflaz H., Elitok A., et al.

Renal failure , cilt.31, sa.9, ss.807-13, 2009 (SCI-Expanded)

153. Steroid Therapy in Initial Treatment of Idiopathic Membranous Nephropathy

Ozturk S., Kucuk H., YAZICI H., Kucuk M., Celik V., Uzun S., et al.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.18, sa.2, ss.62-68, 2009 (ESCI)

154. Coronary flow reserve dysfunction in hemodialysis and kidney transplant patients.

Caliskan Y., Oflaz H., Demirturk M., Yazici H., Turkmen A., Cimen A., et al.

Clinical transplantation , cilt.22, sa.6, ss.785-93, 2008 (SCI-Expanded)

155. Effect of Cyclosporin A and Tacrolimus on sister chromatid exchange frequency in renal transplant patients

Ozturk Ş., Ayna T. K., Cefle K., Palanduz S., Ciftci H., Kaya Ş., et al.

GENETIC TESTING , cilt.12, sa.3, ss.427-430, 2008 (SCI-Expanded)

156. A case of fluoxetine-induced syndrome of inappropriate antidiuretic hormone secretion

Ozturk S., Ozsenel E. B., Kazancioglu R., Turkmen A.

Nature Clinical Practice Nephrology , cilt.4, sa.5, ss.278-282, 2008 (SCI-Expanded)

157. Reduced Coronary Flow Reserve and Early Diastolic Filling Abnormalities in Patients with Nephrotic Syndrome

Oflaz H., Sen F., Bayrakli S. K., Elitok A., Cimen A. O., Golcuk E., et al.

RENAL FAILURE , cilt.30, sa.9, ss.914-920, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

158. Reduction or Discontinuation of Calcineurin Inhibitors and Corticosteroids in Immunosuppressive Treatment Protocol

TÜRKMEN A.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.17, ss.29-32, 2008 (ESCI)

159. SIROLIMUS ASSOCIATED INTERSTITIAL PNEUMONITIS IN A RENAL TRANSPLANT PATIENT: IS ITAHYPERSENSITIVITY RESPONSE?

Caliskan Y., Ecder S. A., Guven D., Ozkan O., Ecder T., TÜRKMEN A., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.70, sa.1, ss.19-22, 2007 (ESCI)

160. CORONARYARTERY CALCIFICATION IN PATIENTS UNDERGOING RENALREPLACEMENT THERAPIES

Acarturk G., KAZANCIOĞLU R., Memisoglu E., Tepe S., Caliskan Y., TÜRKMEN A., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.70, sa.1, ss.1-5, 2007 (ESCI)

161. A renal transplant patient with a solitary plasmacytoma in the oral cavity

Caliskan Y., Ozturk S., Demirturk M., Ozkan O., Yazici H., Ecder T., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.21, sa.6, ss.1741-1742, 2006 (SCI-Expanded)

162. Isolated hepatic tuberculous abscess in a renal transplant recipient

CALISKAN Y., DEMIRTURK M., Cagatay A. A., GUVEN D., OZKAN O., ECDER T., et al.

TRANSPLANTATION PROCEEDINGS , cilt.38, sa.5, ss.1341-1343, 2006 (SCI-Expanded)

163. Changes in endothelial function before and after renal transplantation

Oflaz H., Turkmen A., Turgut F., Pamukcu B., Umman S., Ucar A., et al.

TRANSPLANT INTERNATIONAL , cilt.19, sa.4, ss.333-337, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

164. Utilization of elderly donors in living related kidney transplantation

Sahin S., Sahin G., Turkmen A., Sever M.

TRANSPLANTATION PROCEEDINGS , cilt.38, sa.2, ss.385-387, 2006 (SCI-Expanded)

165. Kronik böbrek yetersizliğinde renal replasman tedavilerinin (diyaliz ve transplantasyon) üremik polinöropati üzerine etkilerinin karşılaştırılması

Kayacan D., Kayacan S. M., BASLO M. B., Yıldız A., ERTAŞ M., Türkmen A., et al.

İSTANBUL TIP FAKÜLTESİ DERGİSİ , cilt.69, ss.75-80, 2006 (Hakemli Dergi)

166. Hyperhomocysteinemia in chronic renal failure patients: relation to tissue factor and platelet aggregation

CETIN Ö., Bekpinar S., UNLUCERCI Y. M. Y., TURKMEN A., BAYRAM C., ULUTIN T.

CLINICAL NEPHROLOGY , cilt.65, sa.2, ss.97-102, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

167. THE COMPARISON OF THE EFFECTIVENESS OF RENAL REPLACEMENT THERAPIES (DIALYSIS AND TRANSPLANTATION) ON UREMIC POLYNEUROPATHY IN CHRONIC RENAL FAILURE

Kayacan D., Kayacan S. M., BASLO M. B., YILDIZ A., Ertas M., TÜRKMEN A., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.69, sa.3, ss.75-79, 2006 (ESCI)

168. Acute Renal Failure in Renal Transplant Patients

TÜRKMEN A.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.15, ss.61-64, 2006 (ESCI)

169. Fuzzy organ allocation system for cadaveric kidney transplantation

Gundogar E., Duran F., Canbolat Y., Turkmen A.

TRANSPLANTATION , cilt.80, sa.12, ss.1648-1653, 2005 (SCI-Expanded)

170. A rare post-transplant malignancy, cerebellar hemangioblastoma: a case report.

Ozturk S., Soyluk Ö., Gorcin S., Alisir S., Guven D., Turkmen A., et al.

Journal of nephrology , cilt.18, sa.6, ss.781-2, 2005 (SCI-Expanded)

171. Clinical and molecular characterization of two adults with autosomal recessive Robinow syndrome

Tufan F., Cefle K., Turkmen S., Turkmen A., Zorba U., Dursun M., et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A , sa.2, ss.185-189, 2005 (SCI-Expanded)

172. Kaposi's sarcoma in renal transplant patients: Predisposing factors and prognosis

Berber I., Altaca G., Aydin C., Dural A., Kara V., Yigit B., et al.

TRANSPLANTATION PROCEEDINGS , cilt.37, sa.2, ss.967-968, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

173. EVALUATION OF CLINICOPATHOLOGICAL FINDINGS OF 513 KIDNEY BIOPSIES

Ecder S. A., KILIÇASLAN I., Ecder T., TÜRKMEN A., Ozagari A., Uysal V., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.68, sa.2, ss.43-45, 2005 (ESCI)

174. Endothelial dysfunction in renal transplant patients is closely related to serum cyclosporine levels

Mercanoglu F., Turkmen A., Kocaman O., Pinarbasi B., Dursun M., Selcukbiricik F., et al.

TRANSPLANTATION PROCEEDINGS , cilt.36, sa.5, ss.1357-1360, 2004 (SCI-Expanded)

175. Is there a relation between duration of cyclosporine usage and right and left ventricular function in renal transplant patients?: Tissue Doppler echocardiography study

Oflaz H., Turkmen A., Kocaman O., Erdogan D., Meric M., Oncul A., et al.

TRANSPLANTATION PROCEEDINGS , cilt.36, sa.5, ss.1380-1384, 2004 (SCI-Expanded)

176. Does the endothelial function change in renal transplant patients with longer duration of exposure and with higher cumulative doses of cyclosporine?

MERCANOGLU F., OFLAZ H., TURKMEN A., KOCAMAN O. H., BUNYAK B., UMMAN S., et al.

TRANSPLANTATION PROCEEDINGS , cilt.36, sa.5, ss.1361-1366, 2004 (SCI-Expanded)

177. The effect of calcineurin inhibitors on endothelial function in renal transplant recipients

Oflaz H., Turkmen A., Kazancioglu R., Kayacan S., Bunyak B., Genchallac H., et al.

CLINICAL TRANSPLANTATION , cilt.17, sa.3, ss.212-216, 2003 (SCI-Expanded)

178. Serum potassium in the crush syndrome victims of the Marmara disaster

Sever M., Erek E., Vanholder R., Kantarci G., Yavuz M., Turkmen A., et al.

CLINICAL NEPHROLOGY , cilt.59, sa.5, ss.326-333, 2003 (SCI-Expanded)

179. The outcome of pregnancy among patients receiving hemodialysis treatment.

Kazancioglu R., Sahin S., Has R., Turkmen A., Ergin-Karadayi H., Ibrahimoglu L., et al.

Clinical nephrology , cilt.59, sa.5, ss.379-82, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma

180. Effect of calcineurin inhibitors on QT dispersion in renal transplant recipients

TURKMEN A., BUNYAK B., OFLAZ H., KUCUK M., SAHIN S., Bugra Z., et al.

TRANSPLANTATION PROCEEDINGS , cilt.34, sa.7, ss.2996-2998, 2002 (SCI-Expanded)

181. Severe alloimmune hemolytic anemia after renal transplantation

Odabas A., Tutucu K., Turkmen A., Keskin H., Sever M.

NEPHRON , cilt.92, sa.3, ss.743-745, 2002 (SCI-Expanded)

182. The evaluation of oxidative stress in patients with chronic renal failure

Erdogan C., Unlucerci Y., Turkmen A., Kuru A., Cetin O., Bekpinar S.

CLINICA CHIMICA ACTA , cilt.322, sa.1-2, ss.157-161, 2002 (SCI-Expanded)

183. The characteristics of infections in crush syndrome

Kazancioglu R., Cagatay A., Calangu S., Korular D., Turkmen A., Aysuna N., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.8, sa.4, ss.202-206, 2002 (SCI-Expanded)

184. Favorable outcome of isolated membranous nephropathy in an allogeneic stem cell recipient

Kalayoglu-Besisik S., Yurci A., Yenerel M. N., KAZANCIOĞLU R., Turkmen A., Kilicarslan Y., et al.

BONE MARROW TRANSPLANTATION , cilt.29, 2002 (SCI-Expanded)

185. Renal transplantation in amyloidosis secondary to familial Mediterranean fever

Sever M., Turkmen A., Sahin S., Yildiz A., Ecder T., Kayacan M., et al.

TRANSPLANTATION PROCEEDINGS , cilt.33, ss.3392-3393, 2001 (SCI-Expanded)

186. Outcome of living unrelated (commercial) renal transplantation

Sever M., Kazancioglu R., Yildiz A., Turkmen A., Ecder T., Kayacan S., et al.

KIDNEY INTERNATIONAL , cilt.60, sa.4, ss.1477-1483, 2001 (SCI-Expanded)

187. Successful therapy combined with surgery for severe post-transplant nocardiosis

Kayacan S., Turkmen A., Alis H., Imer M., Barlas O., Ecder S., et al.

JOURNAL OF NEPHROLOGY , cilt.14, sa.4, ss.304-306, 2001 (SCI-Expanded)

188. Cardiac and intestinal amyloidosis in a renal transplant recipient with familial Mediterranean fever

Yildiz A., Akkaya V., Kilicaslan I., Turkmen A., Gorcin B., Atilgan D., et al.

JOURNAL OF NEPHROLOGY , cilt.14, sa.2, ss.125-127, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

189. Polyarteritis nodosa in patients with Familial Mediterranean fever (FMF): A concomitant disease or a feature of FMF?

Ozen S., Ben-Chetrit E., Bakkaloglu A., Gur H., Tinaztepe K., Calguneri M., et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.30, sa.4, ss.281-287, 2001 (SCI-Expanded)

190. The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study.

Türk S., Yildiz A., Tükek T., Akkaya V., Aras U., Türkmen A., et al.

International urology and nephrology , cilt.32, ss.713-6, 2001 (SCI-Expanded)

191. The outcome of patients presenting with crush syndrome after the Marmara earthquake

Kazancioglu R., Korular D., Sever M., Turkmen A., Aysuna N., Kayacan S., et al.

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS , cilt.24, sa.1, ss.17-21, 2001 (SCI-Expanded)

192. Relationship between gingival hyperplasia and class II histocompatibility antigens in renal transplant recipients

Turkmen A., Ak G., Furuncuoglu Y., Akar U., Seyhun Y., Turk S., et al.

NEPHRON , cilt.84, sa.1, ss.29-31, 2000 (SCI-Expanded)

193. Akademik Dental

AK G., TÜRKMEN A., ÜNÜR M., SEVER M.

Akademik Dental , cilt.1, ss.20-3, 1999 (Hakemli Dergi)

194. The prognostic importance of severity and type of post-transplant proteinuria

Yildiz A., Erkoc R., Sever M., Turkmen A., Ecder S., Turk S., et al.

CLINICAL TRANSPLANTATION , cilt.13, sa.3, ss.241-244, 1999 (SCI-Expanded)

195. Transplantation in renal amyloidosis

Turkmen A., Yildiz A., Erkoc R., Ecder T., Gorcin B., Turk S., et al.

CLINICAL TRANSPLANTATION , cilt.12, sa.5, ss.375-378, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

196. Kaposi's sarcoma after renal transplantation in Turkey

Ecder S., Sever M., Yildiz A., Turkmen A., Kayacan S., Kilicaslan I., et al.

CLINICAL TRANSPLANTATION , cilt.12, sa.5, ss.472-475, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

197. Improvement of uremic autonomic dysfunction after renal transplantation: A heart rate variability study

Yildiz A., Sever M., Demirel S., Akkaya V., Turk S., Turkmen A., et al.

NEPHRON , cilt.80, sa.1, ss.57-60, 1998 (SCI-Expanded)

198. Fever in dialysis patients with recently rejected renal allografts

Sever M., Turkmen A., Yildiz A., Ecder T., Orhan Y.

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS , cilt.21, sa.7, ss.403-407, 1998 (SCI-Expanded)

199. Tuberculosis after renal transplantation: experience of one Turkish centre

Yildiz A., Sever M., Turkmen A., Ecder T., Besisik F., Tabak L., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.13, sa.7, ss.1872-1875, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

200. Effects of zinc supplementation on the immune system and on antibody response to multivalent influenza vaccine in hemodialysis patients

Turk S., Bozfakioglu S., Ecder S., Kahraman T., Gurel N., Erkoc R., et al.

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS , cilt.21, sa.5, ss.274-278, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

201. Posttransplant malaria

Turkmen A., Sever M., Ecder T., Yildiz A., Aydin A., Erkoc R., et al.

TRANSPLANTATION , cilt.62, sa.10, ss.1521-1523, 1996 (SCI-Expanded) Sürdürülebilir Kalkınma

202. Successful treatment of Kaposi's sarcoma in a renal allograft recipient

Sever M., Turkmen A., Yildiz A., Ecder T.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.11, sa.1, ss.223, 1996 (SCI-Expanded)

203. LIVING UNRELATED KIDNEY-TRANSPLANTATION IN INDIA - HIGH-RISK OF COMPLICATIONS OTHER THAN THE WELL-KNOWN ETHICAL PROBLEM

SEVER M., ECDER S., AYDIN A., TURKMEN A., KILICASLAN I., CALANGU S., et al.

KIDNEY INTERNATIONAL , cilt.48, sa.5, ss.1679, 1995 (SCI-Expanded)

204. THE FREQUENCY OF IGA NEPHROPATHY IN PRIMARY GLOMERULAR-DISEASE AND THE DIAGNOSTIC-VALUE OF SKIN PUNCH BIOPSY AND SERUM IMMUNOGLOBULIN LEVELS

YILDIZ A., TUNA S., SEVER M., SARICA R., ECDER S., TURKMEN A., et al.

KIDNEY INTERNATIONAL , cilt.48, sa.5, ss.1678, 1995 (SCI-Expanded)

205. KAPOSIS-SARCOMA IN RENAL-TRANSPLANT RECIPIENTS

ECDER S., SEVER M., ARK E., TURKMEN A., YILDIZ A., KILICARSLAN I., et al.

KIDNEY INTERNATIONAL , cilt.48, sa.5, ss.1677, 1995 (SCI-Expanded)

206. CADAVERIC KIDNEY-TRANSPLANTATION ACTIVITIES IN ISTANBUL

AYDIN A., DIBEKOGLU M., TURKMEN A., CARIN M., ELDEGEZ U.

TRANSPLANTATION PROCEEDINGS , cilt.27, sa.5, ss.2947, 1995 (SCI-Expanded)

207. LIVING UNRELATED (PAID) KIDNEY-TRANSPLANTATION IN THIRD-WORLD COUNTRIES - HIGH-RISK OF COMPLICATIONS BESIDES THE ETHICAL PROBLEM

SEVER M., ECDER T., AYDIN A., TURKMEN A., KILICASLAN I., UYSAL V., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.9, sa.4, ss.350-354, 1994 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 200

1. EFFECTS OF DIFFERENT VOLATILE ANESTHETICS ON ANTI-INFLAMMATORY CYTOKINE TGF-BETA1 REALEASE IN LIVING RENAL TRANSPLANT RECIPIENTS

Savran Karadeniz M., Şentürk Çiftçi H., Türkmen A., Oğuz F.

10th Ispec International Conference on Medical & Health Sciences. , 2 - 09 Eylül 2025, ss.1-5, (Tam Metin Bildiri)

2. Böbrek nakli alıcılarında LIMS1 rs893403 genotiplerinin posttransplant glomerülonefritle ilişkisi

MİRİOĞLU Ş., DİRİM A. B., OTO Ö. A., ARTAN A. S., HÜRDOĞAN Ö., ÖZTÜRK S., et al.

41. Ulusal Nefroloji Kongresi, Antalya, Türkiye, 4 - 08 Aralık 2024, ss.14, (Özet Bildiri)

3. Bloodstream Infection Caused By Moraxella nonliquefaciens In A Kidney Transplant Patient

Özden M. D., Akgün Karapınar D. B., Demir E., Türkmen A., Öngen B.

33th International Congress of Antimicrobial Chemotherap, İstanbul, Türkiye, 3 - 06 Kasım 2024, (Yayınlanmadı)

4. Retrospective evaluation of etiology, clinical and laboratory findings in patients diagnosed with secondary and genetic FSGS

Yilmaz A., SULEYMANOVA V., DİRİM A. B., KALAYCI T., ARTAN A. S., OTO Ö. A., et al.

61st Congress of European-Renal-Association (ERA), Stockholm, İsveç, 23 - 26 Mayıs 2024, (Özet Bildiri)

5. HLA-A,-B,-C,-DRB1,-DQB1 allele frequency in renal transplant patients with a diagnosis of COVID-19

Şentürk Çiftçi H., Demir E., Süleymanoğlu M., Artan A. S., Çınar Ç., Bakkaloğlu H., et al.

Annual EFI region 8 Balkan EPT meeting, Sofija-Grad, Bulgaristan, 3 - 05 Kasım 2023, ss.4, (Özet Bildiri) Sürdürülebilir Kalkınma